VpH and Original Breeders League (OBL) have announced a partnership to develop the first federally recognized framework for cannabis genetic quality control in the United States.
This initiative is centered around a white paper, designed as a strategic regulatory blueprint for both state and federal agencies. The document aims to standardize genetic classification, ensure regulatory compliance, and enhance public safety, positioning the cannabis industry for responsible federal legalization.
The fragmented state-by-state regulations governing cannabis have led to inconsistencies in quality, testing, and compliance. As the federal government moves closer to nationwide cannabis reform, a science-backed regulatory framework is essential.
The VpH–OBL partnership aims to achieve several key objectives. First, it seeks to create a federally recognized cannabis genetic classification system to ensure consistent cannabinoid profiles, which will allow for predictable medical and consumer use. Additionally, the partnership plans to implement patent-protected testing protocols using VpH's BioSync™ Platform to standardize potency, contaminant screening, and genetic authentication. Finally, the collaboration aims to develop a unified compliance roadmap to align U.S. cannabis commerce with global pharmaceutical-grade quality standards.
"This white paper is a foundational step toward securing the future of cannabis as a federally recognized industry," said Dr. Elias Jackson, Senior Vice President of VpH. "With OBL, we are delivering the science and structure regulators need to ensure consumer safety, medical efficacy, and industry-wide accountability."
For more information:
Original Breeders League
oblintl.com/
Vyripharm Biopharmaceuticals
vyripharmbio.com/